Pharmaceutical Manufacturing Research Services asks FDA not to approve an NDA for Remoxy ER or similar opioid NDAs.
FDA launches a new staff recruitment and retention campaign.
FDA releases its latest batch of Warning Letters that includes one medical product company Lee Silsby Compounding Pharmacy.
FDA approves an AbbVie NDA for Orilissa (elagolix), the first oral gonadotropin-releasing hormone antagonist specifically developed for women with mod...
Federal Register notice: FDA makes available a draft guidance entitled Inborn Errors of Metabolism That Use Dietary Management: Considerations for Opt...
FDA publishes a draft guidance on using liquids and soft foods as a drug administration vehicle.
On the same day Public Citizen filed a lawsuit against it, FDA 7/23 partially grants the activist groups objective: a ban on cesium chloride use in dr...
FDA posts a draft guidance on Inborn Errors of Metabolism That Use Dietary Management: Considerations for Optimizing and Standardizing Diet in Clinica...